nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts from HSG 2018
|
|
|
2018 |
15 |
4 |
p. 1168-1214 |
artikel |
2 |
Abstracts from HSG 2018
|
|
|
|
15 |
4 |
p. 1168-1214 |
artikel |
3 |
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model
|
Kim, Julius W. |
|
2018 |
15 |
4 |
p. 1127-1138 |
artikel |
4 |
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model
|
Kim, Julius W. |
|
|
15 |
4 |
p. 1127-1138 |
artikel |
5 |
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
|
Rodriguez-Perez, Ana I. |
|
2018 |
15 |
4 |
p. 1063-1081 |
artikel |
6 |
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
|
Rodriguez-Perez, Ana I. |
|
|
15 |
4 |
p. 1063-1081 |
artikel |
7 |
Autoimmune Myopathies: Updates on Evaluation and Treatment
|
McGrath, Emer R. |
|
2018 |
15 |
4 |
p. 976-994 |
artikel |
8 |
Autoimmune Myopathies: Updates on Evaluation and Treatment
|
McGrath, Emer R. |
|
|
15 |
4 |
p. 976-994 |
artikel |
9 |
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
|
Ovsepian, Saak Victor |
|
2018 |
15 |
4 |
p. 1032-1035 |
artikel |
10 |
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?
|
Ovsepian, Saak Victor |
|
|
15 |
4 |
p. 1032-1035 |
artikel |
11 |
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
|
Tu, Wen-Jun |
|
2018 |
15 |
4 |
p. 1158-1167 |
artikel |
12 |
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
|
Tu, Wen-Jun |
|
|
15 |
4 |
p. 1158-1167 |
artikel |
13 |
Diagnosis and Treatment of Mitochondrial Myopathies
|
Ahmed, Syeda T. |
|
2018 |
15 |
4 |
p. 943-953 |
artikel |
14 |
Diagnosis and Treatment of Mitochondrial Myopathies
|
Ahmed, Syeda T. |
|
|
15 |
4 |
p. 943-953 |
artikel |
15 |
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
|
Zhao, Mo |
|
2018 |
15 |
4 |
p. 966-975 |
artikel |
16 |
Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease
|
Zhao, Mo |
|
|
15 |
4 |
p. 966-975 |
artikel |
17 |
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy
|
Dilena, Robertino |
|
2018 |
15 |
4 |
p. 1112-1126 |
artikel |
18 |
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy
|
Dilena, Robertino |
|
|
15 |
4 |
p. 1112-1126 |
artikel |
19 |
Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
|
Shieh, Perry B. |
|
2018 |
15 |
4 |
p. 840-848 |
artikel |
20 |
Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
|
Shieh, Perry B. |
|
|
15 |
4 |
p. 840-848 |
artikel |
21 |
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments
|
Hamel, Johanna |
|
2018 |
15 |
4 |
p. 863-871 |
artikel |
22 |
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments
|
Hamel, Johanna |
|
|
15 |
4 |
p. 863-871 |
artikel |
23 |
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges
|
Carrillo, Nuria |
|
2018 |
15 |
4 |
p. 900-914 |
artikel |
24 |
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges
|
Carrillo, Nuria |
|
|
15 |
4 |
p. 900-914 |
artikel |
25 |
Inclusion Body Myositis: Update on Pathogenesis and Treatment
|
Naddaf, Elie |
|
2018 |
15 |
4 |
p. 995-1005 |
artikel |
26 |
Inclusion Body Myositis: Update on Pathogenesis and Treatment
|
Naddaf, Elie |
|
|
15 |
4 |
p. 995-1005 |
artikel |
27 |
Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice
|
Liu, Jin-Tao |
|
2018 |
15 |
4 |
p. 1093-1111 |
artikel |
28 |
Inhibition of MyD88 Signaling Skews Microglia/Macrophage Polarization and Attenuates Neuronal Apoptosis in the Hippocampus After Status Epilepticus in Mice
|
Liu, Jin-Tao |
|
|
15 |
4 |
p. 1093-1111 |
artikel |
29 |
Ketogenic Diets for Adult Neurological Disorders
|
McDonald, Tanya J. W. |
|
2018 |
15 |
4 |
p. 1018-1031 |
artikel |
30 |
Ketogenic Diets for Adult Neurological Disorders
|
McDonald, Tanya J.W. |
|
|
15 |
4 |
p. 1018-1031 |
artikel |
31 |
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
|
Fu, Chao |
|
2018 |
15 |
4 |
p. 1139-1157 |
artikel |
32 |
LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway
|
Fu, Chao |
|
|
15 |
4 |
p. 1139-1157 |
artikel |
33 |
L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease
|
Polis, Baruh |
|
2018 |
15 |
4 |
p. 1036-1054 |
artikel |
34 |
L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer's Disease
|
Polis, Baruh |
|
|
15 |
4 |
p. 1036-1054 |
artikel |
35 |
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice
|
Belaidi, Abdel A. |
|
2018 |
15 |
4 |
p. 1055-1062 |
artikel |
36 |
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice
|
Belaidi, Abdel A. |
|
|
15 |
4 |
p. 1055-1062 |
artikel |
37 |
Myopathies Related to Glycogen Metabolism Disorders
|
Tarnopolsky, Mark A. |
|
2018 |
15 |
4 |
p. 915-927 |
artikel |
38 |
Myopathies Related to Glycogen Metabolism Disorders
|
Tarnopolsky, Mark A. |
|
|
15 |
4 |
p. 915-927 |
artikel |
39 |
Myopathy: Recent Progress, Current Therapies, and Future Directions
|
Mammen, Andrew L. |
|
|
15 |
4 |
p. 837-839 |
artikel |
40 |
Myopathy: Recent Progress, Current Therapies, and Future Directions
|
Mammen, Andrew L. |
|
|
15 |
4 |
p. 837-839 |
artikel |
41 |
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease
|
LoRusso, Samantha |
|
2018 |
15 |
4 |
p. 872-884 |
artikel |
42 |
Myotonic Dystrophies: Targeting Therapies for Multisystem Disease
|
LoRusso, Samantha |
|
|
15 |
4 |
p. 872-884 |
artikel |
43 |
Pompe Disease: From Basic Science to Therapy
|
Kohler, Lara |
|
2018 |
15 |
4 |
p. 928-942 |
artikel |
44 |
Pompe Disease: From Basic Science to Therapy
|
Kohler, Lara |
|
|
15 |
4 |
p. 928-942 |
artikel |
45 |
Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery
|
Ramos-Perdigués, Sònia |
|
2018 |
15 |
4 |
p. 1082-1092 |
artikel |
46 |
Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery
|
Ramos-Perdigués, Sònia |
|
|
15 |
4 |
p. 1082-1092 |
artikel |
47 |
Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches
|
Lawal, Tokunbor A. |
|
2018 |
15 |
4 |
p. 885-899 |
artikel |
48 |
Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches
|
Lawal, Tokunbor A. |
|
|
15 |
4 |
p. 885-899 |
artikel |
49 |
Skeletal Muscle Channelopathies
|
Phillips, Lauren |
|
2018 |
15 |
4 |
p. 954-965 |
artikel |
50 |
Skeletal Muscle Channelopathies
|
Phillips, Lauren |
|
|
15 |
4 |
p. 954-965 |
artikel |
51 |
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
|
Taylor, Beth A. |
|
2018 |
15 |
4 |
p. 1006-1017 |
artikel |
52 |
Statin-Associated Muscle Disease: Advances in Diagnosis and Management
|
Taylor, Beth A. |
|
|
15 |
4 |
p. 1006-1017 |
artikel |
53 |
The Limb–Girdle Muscular Dystrophies: Is Treatment on the Horizon?
|
Chu, Mary Lynn |
|
2018 |
15 |
4 |
p. 849-862 |
artikel |
54 |
The Limb–Girdle Muscular Dystrophies: Is Treatment on the Horizon?
|
Chu, Mary Lynn |
|
|
15 |
4 |
p. 849-862 |
artikel |